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Abstract.  From rat livers labeled in vivo for 30 min 
with [35S] cys-met, we have isolated two classes of 
vesicular carders operating between the Golgi com- 
plex and the basolateral (sinusoidal) plasmalemma. 
The starting preparation is a Golgi light fraction 
(GLF) isolated by flotation in a discontinuous sucrose 
density gradient and processed through immunoisola- 
tion on magnetic beads coated with an antibody 
against the last 11 aa.  of the pIgA-R tail.  GLF and the 
ensuing subfractions (bound vs nonbound) were lysed, 
and the lysates processed through immunoprecipitation 
with anti-pIgA-R and anti-albumin antibodies followed 
by radioactivity counting,  SDS-PAGE, and fluorogra- 
phy.  The recovery of newly synthesized pIgA-R was 
>90%  and the distribution was 90% vs 10%  in the 
bound vs nonbound subfractions, respectively. Albu- 
min radioactivity was recovered to ,x,80%,  with 20% 
and 80% in bound vs nonbound subfractions, respec- 
tively. 
Other proteins studied were:  (a) secretory- 
apolipoprotein-B, prothrombin,'C3  component of the 
complement, and caeruloplasmin;  (b) membrane- 
transferrin  receptor,  EGR-receptor, asialoglycoprotein 
receptor,  and the glucose transporter.  In all the experi- 
ments we have performed, the secretory proteins dis- 
tributed up to 85 % in the nonbound subfraction (large 
secretory vacuoles), whereas the membrane proteins 
were segregated up to 95 % in the bound subfraction 
(small vesicular carders).  These results suggest that in 
hepatocytes, membrane and secretory proteins are 
transported from the Golgi to the basolateral plas- 
mamalemma by separate vesicular carders as in glan- 
dular cells capable of constitutive and regulated 
secretion. 
H 
EPATOCYTES, like all epithelial,  polarized cells, have 
distinct baso-lateral (sinusoidal)  and apical (biliary) 
plasmalemma domains,  separated by tight junctions. 
Most of their secretion is directed towards the baso-lateral 
domain and reaches the blood plasma through the spaces of 
Disse, but direct secretion at the apical membrane does exist 
(24) as it has been shown for other polarized, epithelial cells 
(9, 20, 21). Hepatocytes are secretory cells of the constitutive 
type; no stimulus  that can trigger  their secretion has been 
identified.  It has been assumed that in constitutive  secretory 
cells membrane and soluble proteins destined for secretion 
are transported to the plasrnalemma  in the same vesicular 
carders (5). 
In previous work, it has been shown that during treatment 
with inhibitors  of microtubule assembly (3, 24), or inhibi- 
tors of secretion (10), newly synthesized secretory and mem- 
brane  proteins  were transported  to the cell  surface with 
different kinetics,  a finding which suggests transport of these 
proteins by different carders. 
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Since our main interest  is the identification  of vesicular 
carders involved in intracellular  traffic, we decided to try to 
isolate  the  carders  that  transport  proteins  at  the  Golgi 
complex-sinusoidal  plasmalemma (sPM)  1 relay. 
The questions we intended  to answer were:  (a) Are the 
secretory and membrane proteins transported together in the 
same vesicular carriers, like in constitutive  secretory cells, 
or are they segregated in different carriers, like in regulated 
secretory ceils? (b) If there is segregation  of soluble from 
membrane proteins on this relay, where does it occur? (c) 
Upon isolation,  would these vesicles represent enough mate- 
rial for further work, such as biochemical characterization 
or reconstituted cell free systems? 
In the past, we have succeeded in isolating  a population 
of transcytotic vesicular carriers  from rat hepatocytes by 
combining a sucrose density gradient centrifugation  with an 
immunoisolation  procedure (30).  We decided to take the 
1. Abbreviations  used in this paper:  APOB, apolipoprotein  B; ASGP-R, 
asialoglycoprotein  receptor;  EGF-R, epidermal  growth  factor  receptor; 
GLF, Golgi light fraction; pIgA-R, polymeric IgA-receptor; sPM, sinusoi- 
dal plasmalemma;  TM, total microsomal. 
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used in our protocol. A TM fraction is loaded at the bottom (left) 
and the fractions which float in different sucrose densities are col- 
lected as depicted by the accolades (right). TM, total microsomes; 
GLF,,  Golgi  light fraction;  GHF, Golgi heavy  fraction;  1.15 M, 
crude vesicular carrier fraction; RME, residual microsomal fraction. 
same approach (with minor modifications), but this time the 
target was the vesicular carriers operating at the Golgi-sPM 
relay. The liver remained the organ of choice because it is 
an abundant source of  material, because fractionation proce- 
dures are well worked out (13) and the kinetics of our marker 
proteins, the polymeric IgA-receptor (pIgA-R) and albumin, 
are well established (17, 19, 22, 24, 29). 
Materials and Methods 
Spragoe-Dawley  rats,  weighing  150-200 g (Banfin & Kingman, Fremont, 
CA) were used in all experiments.  Magnetic beads were kindly provided by 
Dr. J. Ugelstad (Sintef Co., Trondheim, Norway).  A magnetic device was 
purchased from Dynal Inc. (Great Neck, NY). Chemicals and reagents were 
obtained from the following  sources:  [35S] met-cys  and ovalbumin  from 
ICN (Costa Mesa,  CA);  [3H]UDP-Gal,  [125I] and Amplify from Amer- 
sham (Arlington Heights, IL); electrophoresis reagents and Afligel-10 from 
Biorad Labs. (Richmond, CA); affinity purified  goat anti-rabbit IgG (Fc) 
from Biodesign Int. (Kennebunkport, ME); protease inhibitors (Leupeptin, 
Pepstatin,  Apmtinin) from  Boehringer Mannheim Corp.  (Indianapolis, 
IN); protein A-Sepharose from Pbarmacia LKB Biotechnology  (Piscataway, 
NJ); protein A/G Agarose from Santa Cruz Biotechnology  (Santa Cruz, 
CA); XAR-50 film from Eastman Kodak (Rochester,  NY); Ecoscint from 
National Diagnostics  (Atlanta, GA); asialofetuin  from Sigma Chem. Co. 
(St. Louis, MO); ketamine and xylozine (anesthetics) from Aveco Co. (Fort 
Dodge,  IA). All chemicals used were of reagent grade. 
In Vivo Labeling and Fractionation Protocol 
Rat livers were labeled in vivo for 30 rain by injection through the portal 
vein of 1 mCi[35S] met-eys diluted in saline. By 10 rain '~95% of the ra- 
dioactive counts are cleared from the blood plasma (personal unpublished 
results,  see also reference 29), so we can assume that there is a 10-rain in 
vivo pulse followed by a 20-rain spontaneous chase. For preparing the total 
microsomal (TM) standard, the liver was labeled by the same procedure but 
for one hour and with two consecutive injections of radioactive label at time 
=  0  rain and time =  30 rain so as to label all the receptor forms (see 
Results). The fractionation procedure used a discontinuous sucrose density 
gradient as in (13). The livers were flushed with cold 0.25 M sucrose sup- 
plemented with a cocktail of protease inhibitors (Leupeptin, Pepstatin, and 
Aprotinin at 1/~g/ml), collected, and homogenized  1:5 (wt/vol) in the same 
medium. A TM fraction obtained from this homogenate (by centrifugation 
of the posmuclear supernatant at 100,000 g for 90 rain) was resuspended 
in the same medium, and then adjusted to 1.22 M sucrose and loaded at 
the bottom of the gradient shown in Fig. 1. The gradient was spun at 82,000 
g for 3 h and the band floating at 0.25 M-0.86 M interface was collected 
and used as starting material for additional work.  This fraction has been 
designated Golgl light fraction (GLF). 
Immunoisolation 
The immunoisolation  protocol is based on the ability of an antibody insolu- 
b~  onto a solid support (in our case magnetic beads) to specifically re- 
trieve, from a mixture of particles or vesicles carrying different antigens on 
their surface, only those bearing the antigen recognized by the insolubllized 
antibody (15). The advantages of immunoisolation  via magnetic beads are: 
speed, high specificity, bypass of numerous centrifusation steps, (beads are 
retrieved with the help of a magnetic device), and low contamination due 
to the smooth surface, size uniformity, and low hydrophobicity of the beads. 
The beads, which carry free -OH groups on their surface, are first activated 
for 20 h at room temperature by the tosyl-chioride method using pyridine 
as a catalyst (11). The activated beads are first coated with goat anti-rabbit 
IgG (Fc) (secondary antibody), which is expected to bind in the fight orien- 
tation  the specific, primary antibody introduced  at the next step. In our case, 
the primary antibody was raised in rabbits against a synthetic peptide repro- 
ducing the last 11 amino-acids (AAQVHDGPQEA)  of the COOH terminus 
of the rat polymeric IgA-receptor  (i). FOr immunizing the rabbits, the pep- 
tide was coupled to a carrier protein (bovine  albumin) by the glutaraldehyde 
method (11). The primary antibodies (anti-plgA-R tail) were affinity purified 
(on a peptide-Afligel-10 column), in order to increase the surface concentra- 
tion of the specific antibody on the magnetic beads. Magnetic beads, coated 
with '~10/~g affinity purified IgG/mg beads, were incubated for 2-12 h (with 
gentle agitation, on an end-over-end rotator) with the starting material (SM) 
which was GLF in sucrose, as collected from the gradient, diluted 3.'7 with 
5% FCS, 2 mM EDTA in PBS (SPBS). Of the many blocking agents tried, 
FCS was found to be the most effective in lowering nonspecific binding. At 
the end of the incubation the beads with the attached vesicles were washed 
with SPBS (6 ×  15 mill). The nonbound subfraction was always saved for 
analysis. In this way, the SM is resolved in two subfractions:  nonbound  (NB) 
and bound (B), respectively. 
Antibodies 
Antibodies used were either raised in our laboratory or obtained from the 
following sources:  (a) anti-pIgA-R  ectodomain, (raised in our laboratory 
against  the secreted fragment of  the receptor isolated from bile) used mostly 
for immunoprecipitation  studies and previously characterized (22); (b) anti- 
pIgA-R taft, raised in our laboratory against a synthetic  peptide representing 
the last 11 a.a. of the carboxyterminal domain of the rat pIgA-R sequence 
(1); this antibody recognizes the receptor by immunoblotting, immunopre- 
cipitation, and works very well in immunoisolation; it does not recognize 
the biliary form of the receptor,  i.e., the ectodomain, and does not cross- 
react with any other proteins in fraction lysates; (c) sheep antibodies against 
rat albumin, rat transferrin, rat C3 complement, human caeruloplasmin, 
rat dimeric IgA, and aikaline phosphatase-conjngated anti-sheep IgG were 
from The Binding Site  (San Diego,  CA); (d) alkaline phospbatase-con- 
jngated anti-rabbit and anti-mouse IgG were from Sigma Chem. Co.; (e) 
gold conjugated anti-rabbit  IgG was from Zymed (San Francisco, CA). Ad- 
ditionai antibodies were obtained from the following laboratories: (f) anti- 
rat prothrombin  from Dr. R. Horvath  (University  of Vienna, Austria); (g) 
anti-rat apolipoprotein B from Dr. Elovson (UCLA); (h) anti-rat asialogly- 
coprotein receptor from Dr. K. Drickamer (Columbia  College of Physicians 
and Surgeons);  (i) anti-human U'ansferrin receptor endodomain, which 
cross-reacts  with the rat receptor, from Dr. I. Trowbridge (Salk Inst.); q) 
anti-rat epidermal growth  factor receptor from Dr.  G. Gill (UCSD); (k) 
anti-rat glucose transporter from East Acres  Biologlcais  (Southbridge, 
MA); (l) anti-Ce-9,  an antibody that recognizes a sinusoidai plasma mem- 
brane antigen from Dr. A. Hubbard (Johns Hopkins,  Baltimore,  MD); (m) 
anti-rat a-mannosidase II from Dr.  M. G. Farqubar CLICSD); (n) anti-rat 
c~-2,6 siaiyltransferase  from Dr. K. Colley (University of Chicago, IL). Im- 
munoprecipitations and Western blotting were done as in (30). 
Electron Microscopy 
Electron microscopy was performed to survey the composition of SM (i.e., 
GLF) and NB and to visualize the elements immunoisolatnd on the mag- 
netic beads (B). SM, N-B, and B were fixed in 4% paraformaldehyde,  0.1% 
glutaraldehyde  in cacodylate-HCl  buffer (pH =  7.2), for 45 rain, and then 
in 1% osmium tetroxide in the same buffer for 1 h. For the SM and NB, 
better results were obtained by omitting the first fixation step. The samples 
were  stained in block in 2 % uranyl acetate, dehydrated  in ethanol and 
propylene oxide and embedded in Epon. Thin sections were cut, stained, 
and examined in a Phillips TEM. For immunocytochemical identification, 
the vesicles on the beads,  were first reacted with anti-pIgA-R tail antibody 
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30 rain. Immunoprecipitations using an antibody which recognizes 
the ectodomain of  the pIgA-R (dilution 1:30) were carried out from 
the fractions collected from the gradient in Fig. 1. Equal amounts 
of  protein/sample were used. Newly synthesized 116K  is highly en- 
riched in GLF. No mature form (120K) is yet present at the time 
tested, when compared with the standard control lane. 
(1 h) followed  !  V goat  anti-rabbit IgG conjugated  to 10 nm gold (1 h). The 
beads were then washed (3 x  15 rain), fixed, and processed  as above. 
Radioiodination 
Radioiodination  of  asiaiofetuin  was  performed by  the  Iodogen  method (25). 
[125I] asialofetuin  (3 x 10  a cpm)  was injected  intraportaily  at time = 0 and 
at time = 6 min the liver  was removed  and fractionated  as given  above.  The 
fractions  and subfractions  obtained  were  counted  in a gamma  counter  (5500 
B, Beckman Instrs., Fullerton, CA). 
A hybridoma  cell line secreting  dimeric  IgA was kindly  provided  by Dr. 
D. Bole  (Ann  Arbor, MI). The cells  were biosynthetically labeled overnight 
with 100 ~Ci [35S]met-cys/ml,  and the tissue culture supernatant was con- 
centrated  about 10 times  using  a Centriprep  device  (Amicon,  Beverly,  MA). 
5 x  104 cpm in dIgA (as determined  by immunoprecipitation)  were in- 
jected  into  the portal  vein; 12 min later  the liver  was removed  and processed 
as usually. Counts specific  for dlgA were followed  in the different  fractions 
IV scintillation  counting  and by specific  immunoprecipitations,  followed  IV 
SDS-PAGE and fluorography. 
Results 
A  Fraction Enriched in the Elements of the 
Exocytic Pathway 
Since our main interest was the isolation of  vesicular carriers 
plying between the Golgi complex and sPM, we took advan- 
tage of the fact that the kinetics of the pIgA-R and albumin 
transport along the secretory pathway have been established. 
In a pulse/spontaneous chase in vivo labeling, it takes ,x,30 
rain for the receptor to reach the sPM and 30-35 rain for the 
newly synthesized albumin to reach the blood plasma. Vesic- 
ular carders operating between the Golgi complex and sPM 
(G-sPM-VC), should be characterized by maximum  labeling 
of the newly synthesized albumin and pIgA-R at 30-35 rain 
and by the predominant presence of the intermediary (l16K) 
form of pIgA-R. As shown in previous kinetic studies (29), 
there are three different MW forms of  the pIgA-R correspond- 
ing to different stages of  its posttranslational processing. 105K 
is the ER core glycosylated form (endo H sensitive), l16K 
fully glycosylated, endo H resistant form is present in Golgi, 
and  120K the mature form (phosphorylated) is present in 
sPM and transcytotic vesicles. Fig. 2 shows the result of in 
vivo labeling for 30 min followed by fractionation of  the liver 
and immunoprecipitation of pIgAoR from the ensuing cell 
fractions. We found heavy accumulation of newly synthesized 
116K,  the intermediary form of the pIgA-R, in GLF which 
was in accord with our starting premises. As shown in Fig. 
2, the amount of newly synthesized 116K in the other frac- 
tions collected from the sucrose gradient is much smaller, 
which justifies our selection of GLF as starting material for 
subsequent work. By morphology (Fig. 3), GLF contains in 
addition to large (0.5 #m), lipoprotein loaded vacuoles and 
scattered unstacked Golgi cisternae, small vesicles (80-120 
nm) of the size expected for vesicular carders. These small 
vesicles are tethered to, or budding from, vacuolar or cister- 
nal Golgi elements, or are scattered around apparently free 
(Fig. 3-gallery). Besides the 116K form of the receptor, we 
also immunoprecipitated the 105K form (•10%  of the total 
number of counts in the 116K)  which is the ER, core gly- 
cosylated form of the receptor. We assume that GLF also 
contains ER-Golgi carriers, caught in this fraction on account 
of recycling or present therein as contaminants. We favor the 
first alternative because several attempts to separate the two 
forms of the receptor, by running GLF on a second, continu- 
ous sucrose density gradient, were unsuccessful. As a result 
of these preliminary experiments, we decided to use GLF as 
the starting preparation for the isolation of Golgi-sPM vesic- 
ular carriers. We realize that vesicular carriers of this type 
may be present in lesser amounts in other fractions (GHF 
and 1.15 M); this remains to be established and quantitated 
by further work. 
Immunoisolation of a Specific Class of 
Vesicular Carriers 
Our immunoadsorbent is the magnetic beads coated with a 
specific antibody which only recognizes the endodomain of 
pIgA-R (see Materials and Methods).  Therefore, only the 
vesicles that carry the receptor in the fight orientation, i.e., 
having the endodomain exposed at the surface, are expected 
to bind to the antibody coated magnetic beads. After incuba- 
tion of GLF with the immunobeads, the resulting subfrac- 
tions, i.e., B and NB, were analyzed morphologically and 
biochemicaUy.  Figs.  4  and  5  show  the  two  subfractions 
processed as in Materials and Methods for electron micros- 
copy.  The  NB  subfraction consists  of lipoprotein loaded 
vacuoles and Golgi cisternae, generally well preserved ex- 
cept for some fragmentation and swelling of  the vacuolar ele- 
ments (Fig. 4). The immunoadsorbed vesicles in the bound 
subfraction are predominantly small in size and free of con- 
tent (Fig. 5), but a few small vesicles containing one or a few 
lipoprotein particles are still present, as are occasional Golgi 
cisternae (Fig. 5-gallery). Large lipoprotein containing vac- 
uoles are generally absent. To check for the specificity of the 
immunoadsorption, in one experiment we reacted the immu- 
noadsorbed vesicles, with anti-pIgA-R tail antibodies, using 
as reporter a gold conjugated secondary antibody (see Mate- 
rials and Methods).  The majority of the immunoadsorbed 
vesicles were labeled (Fig. 5 d). 
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GLF  (SM) processed  as  de- 
scribed in Materials and Meth- 
ods.  The  most  abundant 
elements  are  large  secretory 
vacuoles  filled  with  lipopro- 
teins particles; also present are 
scattered, unstacked cisternae 
as well as small vesicular car- 
riers.  The latter appear to be 
tethered to the large elements, 
but a few of them are appar- 
ently free. The gallery on top 
shows different small vesicular 
carriers  again  most of them 
tethered  to or budding  from 
the larger elements. In general, 
these budding vesicles are free 
of dense content.  Arrow in b 
points  to  an  apparently  free 
vesicle,  arrowheads  point  to 
tethered vesicles. Bar, 0.1/~m. 
Segregation of  Albumin from plgA-R Along the 
Secretory Pathway 
After a series of immunoisolation experiments, SM (GLF), 
and  the  subfractions derived  therefrom (NB and  B)  were 
lysed  and  lysate  immunoprecipitations  were  carried  out 
using antibodies against the pIgA-R and albumin, followed 
by  either  scintillation  counting  of the  precipitates  and/or 
SDS-PAGE and fluorography. The distribution as well as the 
recovery of the two proteins in the SM, was followed in the 
subfractions obtained (NB and B).  The data were normal- 
ized to SM volume, taking into account dilution factors and 
differences  in  sample  volumes.  Normalization  to  protein 
amount (enrichment) was not possible because of the pres- 
ence of FCS and extraneous antibodies present in NB and B. 
Fig. 6 shows a bar graph representing the SM pIgA-R distri- 
bution between the NB and B subfractions. The recovery of 
pIgA-R specific counts in NB and B approached 100% of the 
counts in SM. Above the graph, the results of an iramunopre- 
cipitation experiment, followed by SDS-PAGE and fluorog- 
Figure 4. NB subfraction examined by EM, after incubation of the 
SM for 12 h with the beads. Large vacuoles containing lipoprotein 
particles are the predominant component of the preparation which 
also contains a few Oolgi cisternae and a few small vesicles. The 
large vacuoles have intact membranes but their content is of low 
density suggesting swelling and partial extraction.  Bar, 0.1 /~m. 
The Journal of Cell Biology, Volume 125, 1994  736 Figure 5. Composite showing partial view of sectioned magnetic beads, f shows the control sample in which the primary antibodies have 
been omitted, e represents the B subfraction in which most of the vesicles immunoadsorbed on the beads are small in size and free of 
content as compared to the SM (Fig. 3) or NB (Fig. 4). A gallery of vesicles immunoadsorbed on the beads illustrates the occasional 
presence of a few lipoprotein particles in bound vesicles (a), the occasional binding of Golgi cisternae (c), and the positive identification 
of immunoadsorbed vesicles by immunognld labeling (d). Arrows point at small vesicular carriers (b) and arrowheads indicate other ele- 
ments occasionally bound to the beads (a and c). In d, the arrowhead points at a vesicle heavily labeled by immunogold. Bar, 0.5/zm. 
raphy shows that the starting preparation (SM) has primarily 
the 116K form and a smaller amount of 105K; the bound sub- 
fraction(B) contains over 90% of both forms relative to the 
SM fraction whereas NB accounts for less than 10%. Com- 
parison with the standard control lane shows that none of the 
fractions contains the mature 120K form. We assume that 
the 105K form reflects the presence of recycling vesicular 
carriers operating between the ER and Golgi or within early 
Golgi subcompartments. 
Fig. 7 shows the distribution and recovery of  newly synthe- 
sized albumin in the two subfractions. The data were ob- 
tained  by  quantitative  immunoprecipitation  followed  by 
scintillation counting (bar graph) or SDS-PAGE and fluorog- 
raphy (above the graph). Albumin was distributed ~80% vs 
~20%, in the NB vs B, respectively, with recovery rates be- 
tween 80-100% of the amount present in SM. One concern 
was that, during the incubation, albumin may leak out of the 
vesicular carriers into the reaction medium. This possibility 
was checked by pelleting in one replicate experiment the 
nonbound subfraction at 100,000  g for 1 h, and measuring 
the distribution of radioactivity in the pellet and the superna- 
tant. Over 86 % of the radioactivity counts (most of them in 
newly  synthesized albumin)  were  present  in  the  pellet, 
whereas less than 14%  were left in the supernatant. 
Segregation of Other Soluble and Membrane Proteins 
We decided to widen our survey by analyzing the distribu- 
tion of other soluble and membrane proteins between the NB 
and B subfractions. Besides albumin and pIgA-R we followed 
the apolipoprotein B (ApoB), known to be present in GLF 
from previous work (12),  prothrombin,  Cs component of 
complement and caeruloplasmin-as representative soluble 
proteins-and transferrin receptor, epidermal growth factor 
receptor (EGF-R), asialoglycoprotein receptor (ASGP-R), 
and glucose transporter-as membrane proteins.  Fig. 8 shows 
the distribution of SM secretory proteins between NB and 
B. The upper panel shows newly synthesized ApoB detected 
by immunopreeipitafion and fluorography and prothrombin 
detected by immunoprecipitation followed by SDS-PAGE, 
Western blotting, and detection by overlay with p~I] goat 
anti-rabbit IgG,  followed by autoradiography. The  lower 
panel shows the C3 component of complement, and caerulo- 
plasmin detected by Western blotting with specific antibodies, 
Saucan and Palade Hepatocytes Segregate Membrane and Secretory Proteins  737 Figure 6. Bar graph showing the distribution of  SM pIgA-R  between 
the N'B and B subfractions(average of five experiments)  by specific 
immunoprecipitations  followed  by  scintillation  counting  or/and 
SDS-PAGE and fluorography. Distribution  was between 5 % to 30% 
vs 70% to 95 % in NB vs B subfractions,  respectively, with recover- 
ies close to 100%. The fluorography above the graph represents one 
of  the five experiments  in which the distribution  of  the receptor was 
5 % vs 95 % in the NB vs B, respectively. Comparison with the stan- 
dard, control lane shows that no mature form is present. 
Figure 7. Bar graph showing albumin distribution  as an average of 
five experiments.  After immunoisolation samples were processed 
through  immunoprecipitation  with  anti-albumin  antibodies  fol- 
lowed by scintillation  counting or/and SDS-PAGE and fluorogra- 
phy. Distribution  of albumin was between 75% to 85% vs 15% to 
25 % in NB vs B, respectively,  with recoveries between 80-100%. 
Above the graph, the fluorography represents one of  the five experi- 
ments in which the distribution  was 85% vs 15% in the NB vs B, 
respectively. 
followed by donkey anti-sheep  IgG conjugated to alkaline 
phosphatase. ApoB distribution, like albumin was quantitated 
by following the biosynthetically labeled (newly synthesized) 
proteins,  whereas the others were detected at  steady state 
using  radioactive  or alkaline  phosphatase-tagged  reporter 
antibodies. In all cases, the distribution followed the albumin 
pattern. 
The only exception among secretory proteins was transfer- 
fin which distributed  equally between NB and B  in  pulse/ 
spontaneous chase  experiments as  well  as  at  steady  state  (not 
shown). Transfcrrin  may represent  part  of  the cargo of  the 
small vesicles  in the B subfraction. 
Fig.  9  shows  the  membrane proteins  surveyed  in  the  steady 
state  condition.  The corresponding transfers  were overlaid 
with  specific  antibodies  and  the  latter  were  detected  by  using 
alkaline  phosphatase- or ~I-tagged reporter  antibodies.  In 
the  upper  panel,  transferrin-R  and EGF-R overlays  were de- 
tected by  radioiodinated secondary  antibodies and  their 
quantitation  showed that  •90%  of  the  activity  present  in  the 
SM was recovered in  the  B subfraction.  In  the  lower panel, 
ASGP-R and the  glucose transporter  overlays  were detected 
by alkaline  phosphatase-tagged  secondary  antibodies.  We 
have  also  surveyed  the  distribution  of  Ce-9,  a  membrane pro- 
tein  restricted  to  the  sinusoidal  plasmalernma (2),  and found 
Hgure 8. The distribution of secretory proteins is shown by immuno- 
precipitation followed by SDS-PAGE and fluorography for newly 
synthesized APOB, or by Western blotting for prothrombin,  followed 
by radioiodinated  reporter antibody and autoradiography (upper 
panel). C3 complement and caeruloplasmin  were followed at steady 
state  by Western blotting  followed by alkaline  phosphatase-con- 
jugated reporter antibody (lower  panel). Secretory proteins are not 
detected,  or detected at much lower amounts in the B subfraction. 
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ern blotting with specific antibodies followed by radioiodinated 
(upper panel) or alkaline phosphatase-conjugated (lower panel) 
reporter antibodies. None of them was detected in the NB sub- 
fraction. 
it to be distributed >90%  in the B  subfraction (data not 
shown). 
The Immunoadsorbed Fraction Does Not Contain 
Elements  from the Endocytic or Transcytotic Pathways 
Since the integral membrane proteins surveyed are, with the 
exception of Ce-9, either endocytic or transcytotic receptors, 
we had to exclude the presence of endosomes and endocytic 
and transcytotic vesicles in the bound subfraction and thereby 
ensure that the small vesicular carriers immunoisolated in 
our protocol are true, exocytic vesicles. To this intent, we 
followed the uptake and distribution of an endosomal-lyso- 
somal marker (asialofetuin), and a transcytotic marker (di- 
meric IgA), in the fractions collected from the gradient (see 
Fig. 1), as well as in the GLF subfractions obtained by im- 
munoadsorption. Table I shows the distribution of [125I]ASF 
in the fractions initially collected from the sucrose gradient, 
while Fig.  10 shows the distribution of SM (GLF) counts, 
between the NB and B subfractions. Out of the total number 
of counts present in TM, only 9.45 % are present in the GLF, 
and considering that figure as 100% for the immunoadsorp- 
tion step, only 4.5% are adsorbed on the beads. By extrapo- 
lation from the initial TM number of counts, only 0.4 % are 
present in the B subfraction. The dimeric IgA uptake and 
distribution were checked at 12 rain after its infusion in the 
portal vein. Table I also shows the distribution of the TCA 
precipitable dIgA counts in the fractions collected from the 
sucrose gradient. By immunoprecipitation followed  by SDS- 
PAGE and fluorography, no detectable dIgA was found in 
GLF (not shown). We also checked-by Western blotting- 
the steady state distribution of endogenous dIgA in the liver 
fractions collected from the sucrose gradient, but could not 
detect a signal in GLF (not shown). 
Presence of Golgi Markers in the Bound Subfraction 
By immunoblotting followed by lzsI-tagged reporter antibody, 
Figure 10. Bar graph showing the distribution of [1251]ASF  counts 
in SM between NB and B subfractions (average of two experi- 
ments). The counts in SM (GLF) represent only 9.45  % of the total 
TM counts; by extrapolation, the B subfraction contains only 0.4% 
of the same counts. 
we found that 30-35 % of the Golgi proteins, ot-mannosidase 
11 and a-2,6 sialyltransferase  present in the TM fraction, dis- 
tribute in GLF (Table ID. After immunoisolation from GLF 
(SM), the distribution of these proteins was followed by the 
same procedure in the ensuing subfractions and found to be 
40% vs 60% in the NB vs B, respectively. By extrapolation 
to the initial TM fraction, the amount of these two Golgi pro- 
teins present in the B subfracfion represents between 16-23 % 
of the TM content (Table HI). We have also surveyed in a 
few preliminary experiments, another Golgi protein namely 
galactosyltransferase,  by a specific enzymatic assay (14). Its 
distribution closely followed the same pattern as for the other 
Table I. Percent Distribution of TCA Precipitable ASF and 
dlgA Co~ts in Liver Fractions 
Marker*  TM  GLF  GH  1.15 M  RMf 
%  %  %  %  % 
'25I-ASF  100  9.45  33.9  26.8  27.5 
3~S-dIgA  100  3.06  I8.4  20.4  48.9 
Labeled  ASF  and dIgA were  injected  in  the  portal  vein as described  in 
Materials and Methods. The table shows the TCA precipitable counts in the 
different fractions collected from the gradient. Both ASF and dIgA are present 
in very low amounts in GLF (average of two experiments). 
* An endocytic and a transcytotic marker 
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Sialyltransferase  in Subcellular Liver Fractions 
Enzyme  TM  GLF  GH  1.15 M  RMf 
%  %  %  %  % 
a-Mann lI  100  30.0  18.6  19.6  31.5 
a2,6-Sialytr  100  35.0  18.3  18.2  28.5 
a-mannosidase II and cc 2,6-sialyltransferase antigens present in the fractions 
collected from the gradient, were detected by Western blotting followed by 
[~2sI] reporter antibody and exposure to a phosphor-screen. Quantitation was 
done with the help of a Phosphor Imager (Molecular Dynamics, Sunnyvale, 
CA), by counting the specific  bands areas after subtracting the background. 
Table IlL Percent Distribution of Golgi Enzymes in the NB 
and B Subfractions 
Enzyme  TM  SM  biB  B 
%  %  %  % 
or-Mann H  100  30.1  13.4  16.6 
a2,6-Sialyltr.  100  35.0  11.6  23.4 
Golgi antigens were detected immunologically in SM as well as in the ensuing 
NB and B subfractions  (same procedure as for  Table II).  Comparison with the 
TM fraction  shows that  a significant  amount of  these  Golgi antigens  is  present 
in the B subfraction. 
Golgi proteins studied (data not shown). The B subfraction 
appears to be characterized by its high relative content of 
membrane proteins destined for the sinusoidal plasmalemma 
and also by a lower, yet significant content of typical Golgi 
complex proteins  or activities.  The  implications of these 
findings are considered under Discussion. 
Discussion 
By flotation of  a TM fraction in a discontinuous sucrose den- 
sity gradient (see Fig. 1), we have obtained a Golgi light frac- 
tion with a density of 1.06 g/ml (determined by refractometry 
of the collected material). GLF was used as starting material 
for the  immunoisolation step,  and thereby resolved in  a 
population of small vesicles (B subfraction), and a popula- 
tion of large secretory vacuoles (NB subfraction). All the 
membrane proteins surveyed were found segregated in the B 
subfraction (~90 %), whereas nearly all soluble (secretory) 
proteins  tested  were  left  behind  in  the  NB  subfraction 
(~80%).  The  only exception was  transferrin which has 
slower transport kinetics than other secretory proteins (8) 
and-due to its recycling pattern (7,  26)-could represent 
part of  the cargo of  the small vesicular carriers. The presence 
of transferrin in the B subfraction is in accordance with an- 
other study in which transferrin was colocalized with pIgA-R 
in vesicular carriers budding in vitro from a stacked Golgi 
fraction (23).  The segregation of secretory from membrane 
proteins  on  their  way  to  the  sPM  is  advanced  (up  to 
80-90%), but never complete in our 30-min pulse/spontane- 
ous chase,  in vivo experiments. In trying to improve the 
segregation, we have used colchicine (a microtubule inhibi- 
tor), which is known to abolish almost completely albumin 
and lipoprotein secretion from hepatocytes (22, 27), but to 
affect less extensively the transport of membrane proteins to 
the sPM (24).  In the case of colchicine, we increased the 
pulse/spontaneous chase to 55  rain,  which led to  >95% 
segregation of the newly synthesized pIgA-R and albumin, 
between the B vs NB subfractions, respectively. Taken to- 
gether,  these  findings  suggest  that  the  segregation  is  a 
progressive event, less advanced at 30 rain (controls), than 
at 55 rain (colchicine experiments). 
The segregation of secretory from membrane proteins on 
their way to the sPM is reminiscent of constitutive vs regu- 
lated secretion found in other secretory cells (5). The regu- 
lated pathway  involves  a  concentration step  in  secretion 
granules or vacuoles, intracellular storage, and discharge 
triggered by a primary messenger (secretagogue). The hepa- 
tocytes  concentrate and  apparently  store  their  secretory 
products, but so far no trigger for their discharge has been 
identified. These cells appear to represent a mixed secretory 
cell type: they concentrate and store their secretory products 
like cells involved in regulated secretion, but discharge these 
products without the involvement of a  secretagogue,  like 
cells capable of constitutive secretion.  All the membrane 
proteins we have surveyed apparently follow,  as  in other 
cells, a constitutive pathway. 
The protocol followed and the data obtained indicate that 
the vesicular  carriers  isolated  in the B subfraction  are true 
cxocytic  carriers  free  of  contamination by endocytic  elements 
and transcytotic  vesicular  carriers.  While the  exocytic  nature 
of  these  carriers  appears to  be  well  documented, we still  have 
problems posed by the  apparent inhomogeneity of  the  B sub- 
fraction:  the first  is the detection  of  the ER (105K) form of 
plgA-R and the  second is  the  presence of  Golgi antigens  and 
enzyme activities  therein.  Accordingly, we have to  decide if 
these  problems reflect  cell  fractionation  artifacts  (contamina- 
tion)  or represent  physiological  conditions  prevailing  in situ. 
Flotation  of  GLF in  the  low density  sucrose  layer  (density 
=  1.06  g/ml), explained by the presence of VLDL  (12), 
renders contamination  by  microsomes  (density =  1.18 
g/ml), highly  unlikely,  an assumption confirmed by electron 
microscopy. Also unlikely  is  the  contamination by detached 
vesicular carriers  (density =  1.14-1.15  g/ml). On this  ac- 
count we assume that  all  vesicles  apparently  free  in  GLF sec- 
tions  (Fig.  3, b and g) are  in fact  tethered  to  large  Golgi ele- 
ments at  other  levels  in  the  pellet.  The ER form of  the  plgA-R 
(105K) represents  ~I0%  of the total  receptor  counts in the 
B subfraction.  We assume that  its  presence in GLF is duc 
to  vesicular  carrier  membranes caught in  transient  residence 
in  Golgi elements before  recycling  back to  the ER. On mor- 
phological  grounds and on account of  our fractionation  pro- 
tocol,  we believe  that  contamination by microsomcs can bc 
ruled out. 
The presence of Golgi antigens  and enzyme activities  in 
the  B subfraction  (~20% of  the  TM  content)  could indicate 
that the proteins in case are in transit  for residence in the 
plasmalemma as documented in  other cell  types (28,  31) or 
for  secretion  in  the  blood plasma (4, 18,  28).  Another possi- 
ble  explanation,  which we consider  more likely,  is  that  these 
proteins recycle  back from the plasmalemma  to the Golgi 
complex (16).  Finally,  in  principle  the  membrane of  a  vesicu- 
lar  carrier  could be the  membrane of  one of  the  termini  ser- 
viced by that  carrier,  in this  case the trans  elements of the 
Golgi complex. Substantial  amount of  galactosyl-  and sialyl- 
transferase  (25  % of  the postnuclear supernate content)  was 
detected in a comparable vesicular  fraction  in (6). 
Despite the  presence of  these  Golgi proteins  in  the  B sub- 
fraction,  we do not believe  that  the small  vesicular  carrier 
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Golgi elements. The high degree of segregation between 
soluble  and membrane proteins  is not compatible with me- 
chanical fragmentation during the process of homogeni- 
zation. 
It appears  that the vesicular carriers in the B subfraction 
are formed by progressive segregation of membrane proteins 
followed by continuous budding of the segregated domains 
and final separation during the incubation (in this case in the 
absence of ATP). We assume that the segregation of mem- 
brane proteins is progressive and selective (90 % pIgA-R vs 
50-60%  Golgi antigens) and that our immunoisolated sub- 
fraction, contains mainly small vesicular carders enriched 
in membrane cargo, still carrying Golgi proteins (to be re- 
covered by recycling), in addition to other specific proteins 
that remain to be identified and characterized. 
While our study  presents clear evidence that in hepato- 
cytes  (which  are  considered  to  be  constitutive  secretory 
cells), secretory and membrane proteins segregate in differ- 
ent vesicular carders plying between the Golgi complex and 
sPM, the work so far done represents  only the first step to- 
wards analyzing the composition of these vesicular carriers 
membranes and identifying the critical components involved 
in sorting the cargo as well as in directing and docking these 
vesicles at their fight destinations. 
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